Truist Securities downgraded Northrop Grumman from Buy to Hold, citing that the current share valuation already reflects much of the company’s near-term upside. The analyst reiterated Northrop Grumman’s status as a leading prime contractor across the nuclear triad and key defense platforms but concluded that further multiple expansion is unlikely over the next 12 to 24 months.

Despite the Hold rating, Truist highlighted several potential drivers of revenue and profitability. These include increased B-21 bomber production volumes projected to ramp up by 15% year-over-year beginning in 2026, Northrop’s positioning for the F/A-XX next-generation fighter competition, and anticipated integration of the Integrated Battle Command System into the Department of Defense’s Golden Dome initiative.

Truist noted that Northrop Grumman trades at a roughly 20% premium to its prime defense peers on a price-to-free-cash-flow basis and at a 28% premium versus its own 10-year historical average. The firm warns of potential margin pressure related to higher program costs and free cash flow variability, expecting limited scope for significant earnings or cash flow upside beyond the company’s initial 2026 guidance.